Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized/adverse effects/*therapeutic use
Antineoplastic Agents/adverse effects/*therapeutic use
Carcinoma, Squamous Cell/*drug therapy
Cetuximab
Female
Head and Neck Neoplasms/*drug therapy
Humans
Male
Middle Aged
Quinazolines/adverse effects/*therapeutic use
Receptor, Epidermal Growth Factor/antagonists & inhibitors
Receptor, ErbB-2/antagonists & inhibitors
Treatment Outcome
Young Adult
